# Community Health Azithromycin Trial in Burkina Faso

> **NCT03676764** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 77664 (actual)

## Conditions studied

- Childhood Mortality

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03676764
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 77664 (ACTUAL)
- **Last updated:** 2025-02-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03676764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03676764, "Community Health Azithromycin Trial in Burkina Faso". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03676764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*